Related Experiment Video
Updated: Nov 15, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
WNT inhibition creates a BRCA-like state in Wnt-addicted cancer
Amanpreet Kaur1, Jun Yi Stanley Lim1, Sugunavathi Sepramaniam2
1Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Abstract:
Wnt signaling maintains diverse adult stem cell compartments and is implicated in chemotherapy resistance in cancer. PORCN inhibitors that block Wnt secretion have proven effective in Wnt-addicted preclinical cancer models and are in clinical trials. In a survey for potential combination therapies, we found that Wnt inhibition synergizes with the PARP inhibitor olaparib in Wnt-addicted cancers. Mechanistically, we find that multiple genes in the homologous recombination and Fanconi anemia repair pathways, including BRCA1, FANCD2, and RAD51, are dependent on Wnt/β-catenin signaling in Wnt-high cancers, and treatment with a PORCN inhibitor creates a BRCA-like state. This coherent regulation of DNA repair genes occurs in part via a Wnt/β-catenin/MYBL2 axis. Importantly, this pathway also functions in intestinal crypts, where high expression of BRCA and Fanconi anemia genes is seen in intestinal stem cells, with further upregulation in Wnt-high APCmin mutant polyps. Our findings suggest a general paradigm that Wnt/β-catenin signaling enhances DNA repair in stem cells and cancers to maintain genomic integrity. Conversely, interventions that block Wnt signaling may sensitize cancers to radiation and other DNA damaging agents.
Insights
Wnt signaling supports cancer stem cells and DNA repair. Blocking Wnt with PORCN inhibitors creates a BRCA-like state, sensitizing Wnt-addicted cancers to DNA damaging agents like olaparib.
Area of Science:
- Oncology
- Molecular Biology
- Stem Cell Biology
Background:
- Wnt signaling is crucial for adult stem cell maintenance and contributes to cancer chemotherapy resistance.
- PORCN inhibitors, which block Wnt secretion, show promise in preclinical cancer models and are in clinical trials.
- Wnt signaling's role in DNA repair mechanisms within stem cells and cancers is an area of active investigation.
Purpose of the Study:
- To investigate potential combination therapies for Wnt-addicted cancers.
- To elucidate the mechanistic link between Wnt signaling and DNA repair pathways.
- To explore the role of Wnt signaling in maintaining genomic integrity in stem cells and cancer.
Main Methods:
- Screening for synergistic drug combinations with Wnt inhibitors.
- Utilizing PORCN inhibitors to block Wnt secretion.
- Analyzing gene expression of homologous recombination and Fanconi anemia repair pathways.
- Investigating the Wnt/β-catenin/MYBL2 signaling axis.
- Examining gene expression in intestinal crypts and polyps.
Main Results:
- Wnt inhibition synergizes with the PARP inhibitor olaparib in Wnt-addicted cancers.
- Wnt/β-catenin signaling positively regulates key DNA repair genes (BRCA1, FANCD2, RAD51) in Wnt-high cancers.
- PORCN inhibitor treatment induces a BRCA-like state, suggesting impaired DNA repair.
- This regulatory axis (Wnt/β-catenin/MYBL2) is conserved in intestinal stem cells and upregulated in polyps.
- Wnt signaling enhances DNA repair to maintain genomic integrity in stem cells and cancers.
Conclusions:
- Wnt/β-catenin signaling promotes DNA repair, contributing to genomic stability in stem cells and cancers.
- Blocking Wnt signaling may sensitize cancers to DNA damaging agents, including radiation therapy.
- This study reveals a novel therapeutic strategy by combining Wnt inhibition with DNA damaging agents for cancer treatment.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
The Intrinsic Apoptotic Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity

